Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1997-02-27
2000-02-22
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514561, 514563, A61K 31195
Patent
active
060281073
ABSTRACT:
This invention is a novel method in orthomolecular medicine to sustain favorable amounts of L-arginine efficiently within the human body for preservation of good health and amelioration of various disease states. The method provides administration of sizable amounts of L-citrulline as precursor substance for bioconversion to L-arginine in order to maintain greater blood plasma concentrations of L-arginine as potential substrate for various metabolic functions. The method is useful to increase the availability of substrate for nitric oxide production by constitutive nitric oxide synthases. Embodiments include uses of exogenous L-citrulline for more vasoprotection in sickle cell disease and atherosclerosis, more stability in circulating platelets, more relaxative smooth muscle tone during pregnancy and in achalasia, greater defense against restenosis after angioplasty, greater defense against oxidative stress, enhanced cell stores of creatine, and enhanced fertility in males with oligospermia.
REFERENCES:
Nicolodi et al. (AN 1998067064, Medline, abstract of Int. J. of Clinical Pharmacolgy Research, (1997), 17 (2-3), 85-8), 1997.
Nicolodi et al. (AN 1998067064, Medline, abstract of Int. J. of Clinical Pharmacolgy Research, (1997), 17 (203), 85-8), 1997.
Mandell et al. (AN 970008969, Medline, abstract of Parental Diagonosis, (1996 May), 16 (5), 419-424, 1996.
Armstrong, M.D. et al, "A Study of Plasma Free Amino Acid Levels. II. Normal Values for Children and Adults", Metab. 22:561-569 (1973).
Arnal, J.-F. et al, "Interactions between L-Arginine and L-Glutamine Change Endothelial No Production", J. Clin. Invest. 95:2565-2572 (1995).
Banay-Schwartz, M. et al, "Changes with Aging in the Levels of Amino Acids in Rat CNS Structural Elements: IV. Methionine and Basic Amino Acids", J. Neurosc. Res. 26:217-223 (1990).
Barbul, A., "Arginine: Biochemistry, Physiology, and Therapeutic Implications", J. Parenteral Enteral Nutr. 10:227-238 (1986).
Becker, R.C., "Antiplatelet Therapy", Sci. Med. 3:12-21 (1996).
Bogle, R.G. et al, "Bradykinin and ATP Stimulate L-Arginine Uptake and Nitric Oxide Release in Vascular Endothelial Cells", Biochem. Biophys. Res. Commun. 180:926-932 (1991).
Boysen, G. et al, "Prolongation of Bleeding Time and Inhibition of Platelet Aggregation by Low-Dose Acetylsalicylic Acid in Patients with Cerebrovascular Disease", Stroke 15:241-243 (1984).
Bucala, R. et al, "Advanced Glycosylation Products Quench Nitric Oxide and Mediate Defective Endothelium-dependent Vasodilation in Experimental Diabetes", J. Clin. Invest. 87:432-438 (1991).
Buchmann, I. et al, "Effect of Arginine Administration on Plasma and Brain Levels of Arginine and Various Related Amino Compounds in the Rat", Pharmacol. 53:133-142 (1996).
Buniatan, H.C. et al, "Urea Synthesis by Brain", J. Neurochem. 13:743-753 (1966).
Calloway, D.H., "Nutrition and Reproduction Function of Men", Nutr. Absts. Revs. 53:361-382 (1983).
Caplan, L.R., "Intracranial Branch Atheromatous Disease", Neurol 39:1246-1250 (1989).
Carter, A.J. et al, "Preincubation with Creatine Enhances Levels of Creatine Phosphate and Prevents Anoxic Damage in Rat Hippocampal Slices", J. Neurochem. 64:2691-2699 (1995).
Castillo, L. et al, "Plasma Arginine and Citrulline Kinetics in Adults Given Adequate and Arginine-free Diets", Proc. Natl. Acad. Sci. USA 90:7749-7753 (1993).
Chaudhuri, G. et al, "No is More Important Than PG12 in Maintaining Low Vascular Tone in Feto-Placental Vessels" Am. J. Physiol. 265:2036H-2043H (1993).
Chen, F.-Y. et al, "Arginine Synthesis from Citrulline in Perivascular Nerves of Cerebral Artery", J. Pharmacol. Exptl. Therap. 273:895-901 (1995).
Compo, C. et al, "Aging Abolishes the Renal Response to L-Arginine Infusion in Essential Hypertension", Kidney Intern. 49 (Suppl. 55):S-126-S-128 (1996).
Cooke, J.P. et al, "Antiatherogenic Effects of L-Arginine in the Hypercholesterolemic Rabbit", J.Clin. Invest. 90:1168-1172 (1992).
Cooke, J.P. et al, "Cellular Mechanisms of Atherogenesis and the Effects of Nitric Oxide", Current Opinion Cardiol. 7:799-804 (1992).
Creager, M.A. et al, "L-Arginine Improves Endothelium-Dependent Vasodilation in Hypercholesterolemic Humans", J. Clin. Invest. 90:1248-1253 (1992).
Current Medical Diagnosis and Treatment, 1997, ed. by T.M. Tierney Jr. et al in: 36th ed., Appleton & Lange (1997), pp. 553-554.
De Belleroche, J. et al, in: The Headaches, ed. by J. Olesen et al, Raven Press, (1993), pp. 185-191.
Dhanakoti, S.N. et al, "Renal Arginine Synthesis:Studies in vitro and vivo", Am. J. Physiol. 259:E437-E442 (1990).
Diederich, D. et al, "Endothelial Dysfunction in Mesenteric Resistance Arteries of Diabetic Rats: Role of Free Radicals", Am. J. Physiol. 266:H1153-H1161 (1994).
Dorner, K. et al, "Referenzwerte fur Plasmaaminosauren im Verlauf der Schwangerschaft", Z. Geburtsh. u. Perinat. 197:141-143 (1993).
Drexler, H. et al, "Correction of Endothelial Dysfunction in Coronary Microcirculation of Hypercholesterolaemic Patients by L-Arginine", Lancet 338:1546-1550 (1991).
Duits, A.J. et al, "Enhanced Levels of Soluble VCAM-1 in Sickle Cell Patients and Their Specific Increment During Vasoocclusive Crisis", Clin. Immunol. Immunopathol. 81:96-98 (1996).
Egashira, K. et al, "Evidence of Impaired Endothelium-dependent Coronary Vasodilation in Patients with Angina Pectoris and Normal Coronary Angiograms", New Eng. J. Med. 328:1659-1664 (1993).
Fabricius, M. et al, "Arginine-Nitric Oxide Pathway and Cerebrovascular Regulation in Cortical Spreading Depression", Am. J. Physiol. 269:H23-H29 (1995).
Fitch, W.L. et al, "Plasma Amino Acid, Glucose, and Insulin Responses to Moderate-Protein and High-Protein Test Meals in Pregnant, Nonpregnant, and Gestational Diabetic Women", Am. J. Clin. Nutr. 46:243-249 (1987).
Forstermann, U. et al, "Nitric Oxide Synthase Isozymes", Hypertension 23:1121-1131 (1994).
Francis, R.B. Jr. et al, "Vascular Occlusion in Sickle Cell Disease: Current Concepts and Unanswered Questions", Blood 77:1405-1414 (1991).
Guichard, P. et al, "Diabetic Cardiomyopathy: The Significance of Creatine", Medical Hypotheses 45:41-44 (1995).
Halliwell, B., "Antioxidants in Human Health and Disease", Annu. Rev. Nutr. 16:33-50 (1996).
Hamon, M. et al, "Long-term Oral Administration of L-Arginine Reduces Intimal Thickening and Enhances Neoendothelium-dependent Acetylcholine-induced Relaxation after Arterial Injury", Circulation 90:1357-1362 (1994).
Harker, L.A. et al, "The Role of Platelets in Acute Vascular Events", Circulation 62:Suppl. V, V-13-V-18 (1980).
Harman, D., "Free Radical Involvement in Aging", Drugs & Aging 3:60-80 (1993).
Harris, R.C. et al, "Elevation of Creatine in Resting and Exercised Muscle of Normal Subjects by Creatine Supplementation", Clinical Sci. 83:367-374 (1992).
Heinzel, B. et al, "Ca2+/Calmodulin-dependent Formation of Hydrogen Peroxide by Brain Nitric Oxide Synthase", Biochem. J. 281:627-630 (1992).
Jones, M.E., "Conversion of Glutamate to Ornithine and Proline: Pyrroline-5-Carboxylate, a Possible Modulator of Arginine Requirements", J. Nutr. 115:509-515 (1985).
Kamoun, P. et al, "Citrulline Concentrations in Human Plasma after Arginine Load", Clin. Chem. 37:1287 (1991).
Kanner, J. et al, "Nitric Oxide as an Antioxidant", Archiv. Biochem. Biophys. 289:130-136 (1991).
Kanner, J. et al, "Nitric Oxide, an Inhibitor of Lipid Oxidation by Lipoxygenase, Cyclooxygenase and Hemoglobin", Lipids 27:46-49 (1992).
Kantor, D.B. et al, "A Role for Endothelial No Synthase in LTP Revealed by Adenovirus-Mediated Inhibition and Rescue", Science 274:1744-1748 (1996).
Keller, D.W. et al, "L-Arginine Stimulation of Human Sperm Motility in vitro", Biol. Reproduct. 13:154-157 (1975).
Kerle, K.K. et al, "Exertional Collapse and Sudden Death Associated with Sickle Cell Trait", Mil. Med. 161:766-767 (1996).
Lambert, G.A. et al, "Cortical Spreading Depression Reduces Dura Blood Flow--A Possible Mechanism for Migrain Pain?", Cephalalgia 14:430-436 (1994).
Lauritzen, M., "Pathophysiology of the Migraine Aura--The Spreading Depression Theory", Brain 117:199-210 (1994).
Lauritzen, M., "Pathophysiology of the M
Dees Jos,e G.
Qazi Sabiha N.
LandOfFree
Orthomolecular medical use of L-citrulline for vasoprotection, r does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Orthomolecular medical use of L-citrulline for vasoprotection, r, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orthomolecular medical use of L-citrulline for vasoprotection, r will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-520951